Bioneer Corporation (KOSDAQ:064550)
16,310
-200 (-1.21%)
Apr 25, 2025, 3:30 PM KST
Bioneer Revenue
In the year 2024, Bioneer had annual revenue of 293.98B KRW with 11.68% growth. Bioneer had revenue of 70.43B in the quarter ending December 31, 2024, with 9.85% growth.
Revenue
293.98B
Revenue Growth
+11.68%
P/S Ratio
1.43
Revenue / Employee
523.09M
Employees
562
Market Cap
420.97B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 293.98B | 30.74B | 11.68% |
Dec 31, 2023 | 263.24B | 44.84B | 20.53% |
Dec 31, 2022 | 218.39B | -5.35B | -2.39% |
Dec 31, 2021 | 223.74B | 16.76B | 8.10% |
Dec 31, 2020 | 206.99B | 170.70B | 470.33% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 68.13B |
Peptron | 3.15B |
LigaChem Biosciences | 125.90B |